Pegcrisantaspase API Manufacturers
compare suppliers & get competitive offers
No suppliers found
Sorry, there are currently no suppliers listed for this ingredient. Hopefully we can help you with other ingredients.
Notify me!
Want to be the first to find out when a supplier for Pegcrisantaspase is listed?
Join our notification list by following this page.
Join our notification list by following this page.
List your company
Are you a supplier of Pegcrisantaspase or other APIs and are you looking to list your company on Pharmaoffer?
Click the button below to find out more
Click the button below to find out more
Find CDMO
Looking for a CDMO/CMO that can help you with your pharmaceutical needs?
Click the button below to switch over to the contract services area of Pharmaoffer.
Click the button below to switch over to the contract services area of Pharmaoffer.
Looking for Pegcrisantaspase API 1448590-54-2?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Pegcrisantaspase. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Pegcrisantaspase
- Synonyms:
- Asparec , mPEG-R-Crisantaspase , Pegylated dickeya chrysanthemi l-asparaginase , Pegylated erwinia chrysanthemi l-asparaginase , POLYETHYLENE-GLYCOL-ERWINIA-CHRISANTHEMI-L-ASPARAGINASE
- Cas Number:
- 1448590-54-2
- DrugBank number:
- DB16281
- Unique Ingredient Identifier:
- Y8KTZ6Y35U
General Description:
Pegcrisantaspase, identified by CAS number 1448590-54-2, is a notable compound with significant therapeutic applications. Pegcrisantaspase is under investigation in clinical trial NCT02257684 (A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)).
